Abstract Del(22qll) is a common microdeletion syndrome with an extremely variable phenotype. Besides classical manifestations, such as velocardiofacial (Shprintzen) or DiGeorge syndromes, del(22ql 1) syndrome may be associated with unusual but probably causally related anomalies that expand its phenotype and complicate its recognition. We report here three children with the deletion and a chronic, erosive polyarthritis resembling idiopathic cases
Del(22ql 1) syndrome is a newly recognised contiguous gene syndrome resulting from a (usually) submicroscopic deletion in the proximal part of the long arm of chromosome 22, encompassing in its phenotype Shprintzen velocardiofacial syndrome,' Takao conotruncal anomalies face syndrome, DiGeorge anomaly,2 some instances of Opitz GBBB syndrome type 2,' and isolated outflow tract defects (such as truncus arteriosus, tetralogy of Fallot, or interrupted aortic arch). The incidence could be as high as 1/3500 births.
The spectrum of clinical anomalies associated with 22ql 1 monosomy is remarkably variable. Recently, juvenile rheumatoid arthritis (TRA) has been reported in association with del(22ql 1) in five children. 4 We report here three further cases of this association, indicating that the presence of a JRA-like disorder may not be fortuitous, but rather causally related to the presence of the deletion.
Case reports PATIENT 1 This girl is the second child of unrelated parents, born after an uneventful pregnancy. Clinical investigations at birth showed a tetralogy of Fallot, which was partially surgically corrected at the age of 10 months, pulmonary valvular insufficiency, and peripheral pulmonary stenosis. No other malformations were present. Assessment of calcium metabolism and immunodeficiency are not available from that time, but suspicion of DiGeorge syndrome was never raised in her medical records.
At the age of 4 years ( fig 1A) , she was admitted for painful inflammatory swelling of the knees, for which she was treated with indomethacin and salicylates. Sedimentation ratio was repeatedly high. There was no hepatosplenomegaly. Calcium homeostasis, serum parathormone and thyrocalcitonin, and lymphocyte counts were normal. The clinical course was notable for multiple relapses of the arthritis during the next 15 years, affecting all large and small joints, usually with an important inflammatory component but no fever ("subacute" JRA). Therapy was initially limited to antiinflammatory drugs. Corticosteroids were used from 9 to 18 years and d-penicillamine from 12 to 14 years. There were no ocular manifestations of iridocyclitis or uveitis. At the age of 12, transient non-viral hepatitis was noted. Progressive right ventricular insufficiency was treated with digitalis. Despite corticoids, progressive destruction of the hips and knees led her to become wheelchair bound. Because of progressive flexion deformity, she required tenotomies around the hips and knees at the age of 15 Del(22ql 1) was shown on spread chromosomes hybridised with the specific DNA probe D22S75 and the control probe D22S39 (Oncor), using standard FISH techniques, as recommended by the manufacturer.
The mother suffered recurrent psychiatric problems and had abandoned her daughter during infancy. Features noted in family photographs suggest that she probably also had the deletion. None of the relatives had ankylosing spondylitis, inflammatory bowel disease, uveitis, psoriasis, or psoriatic arthritis (and the same is true for the other two cases). PATIENT 2 This boy is the second child of healthy, unrelated parents. His neonatal course was characterised by low birth weight, hypotonia, and poor feeding. Language development was delayed. Clinical examination at the age of 2 years showed a coarse, expressionless ("myopathic") face ( fig 3A) , brachycephaly with normal OFC, flat nasal bridge, (B) X ray of the hand at the age of 22 showing generalised osteolysis, osteoporosis, and secondary bone fusion.
J7uvenile rheumatoid arthritis and del(22ql 1) syndrome micrognathia, thick helices, short neck, tapering fingers, and transverse palmar creases. X rays showed delayed bone maturation, osteoporosis, and mild platyspondyly. Scans of the heart and head were normal. Later, velopharyngeal insufficiency (without cleft) failed to respond to intensive speech therapy. He had severe gastrooesophageal reflux that necessitated gastrostomy feeding from the ages of 5 to 13. He suffered from chronic constipation and was of short stature (<3rd centile). His full scale IQ was estimated at 58 at the age of 14. Fig 3B and C show his clinical appearance at the age of 12. JRA was diagnosed at the age of 3. The severe course of the disease required treatment with gold, Plaquenil, and methotrexate. At the age of 16, he has severe chronic restrictive joint disease involving the hips, wrists, fingers, and temporomandibular joints. He had had low lymphocyte counts in infancy, but later T and B cell counts were normal. Immunological investigations showed absence of antinuclear antibodies and rheumatoid factor. Immunoglobulin levels were usually normal. CD3, CD4, and CD8 lymphocyte counts were normal, as was the helper/suppressor ratio. Hypocalcaemia was never observed. HLA typing was A1A2-B8B44-CW5CW7-DR4DR17-DRW52DRW53-DQ2DQ3.
Finally, in 1996, karyotyping with probe D22S75 (Oncor) showed a 22ql 1 deletion. PATIENT 3 This child, born in 1990, was the first girl of unrelated French parents. The mother suffered congenital unilateral deafness. Birth weight was 2670 g, length 46 cm, and OFC 34 cm. Clinical investigations at birth showed VSD and camptodactyly of the toes. There were no feeding problems during the first year of life and psychomotor development was not delayed. Severe bilateral deafness was diagnosed at 9 months. At the age of 1 year, she presented with acute polyarthritis affecting large and small joints with mildly increased CRP. JRA was diagnosed and required salycilate and later corticosteroid treatment. She later attended a school for deaf children. She was considered to be of normal intelligence.
When first evaluated aged 7, several dysmorphic features were noted: ridged metopic suture, narrow, upward slanting palpebral fissures, large nose with bulbous tip, small mouth, high vaulted palate with bifid uvula, crowded teeth, small ears, and right posterior embryotoxon. She showed painful ankylosis of the wrists, elbows, ankles, knees, fingers, and toes, with secondary retractions of the small joints. Calcium homeostasis, circulating vitamin A, and PTH were normal. X rays showed osteopenia (confirmed by osteodensitometry) and generalised JRA arthropathy. Immunological investigations showed normal lymphocyte count and the absence of rheumatoid factor and anti-DNA and antinuclear antibodies. CD3, CD4, CD8, and helper/suppressor ratio were in the normal range. HLA genotype was A2A3-B 13B62-CW6-DR13-DQ6.
Karyotyping with probe D22S75 (Oncor) showed a 22ql 1 deletion. The mother was not deleted; the father was not tested. Discussion Del(22ql1) is a multiple congenital anomaly (MCA) syndrome, with a remarkably variable and continually expanding phenotype"'0 that merges Shprintzen velocardiofacial syndrome, most cases of DiGeorge sequence,'" some cases of Robin sequence, and rare, often atypical instances of the CHARGE association. Although phenotypic expression of the disorder has become increasingly better recognised, relatively few data have been recorded on immune dysfunction beyond the neonatal period, during which manifestations of DiGeorge syndrome (with thymic hypoplasia and immunodeficiency) may be observed in roughly 10% of cases. In older children, little or absent lymphoid tissue has been documented in a majority of cases.'2 T cell dysfunction has been observed in the milder cases of DiGeorge syndrome. '3 14 Some case reports mention autoimmune disorders in the syndromes known to belong to the del(22ql 1) spectrum. A single older patient with DiGeorge syndrome has been reported with autoimmune Graves disease.'5 Two adults with del(22ql 1) were recently reported with adult onset idiopathic thrombocytopenia associated in one case with chronic leucopenia.'6 A similar pattern of infantile thrombocytopenia followed by haemolytic anaemia at the age of 8 was mentioned in an abstract. '7 In the report of Pinchas-Hamiel et al,'8 a child with DiGeorge syndrome suffered autoimmune haemolytic anaemia (responding to corticosteroids), thrombocytopenia, and chronic, granulomatous, probably autoimmune hepatitis.
The exact classification of the rheumatoid disease in our cases was the subject of much debate during the preparation of this manuscript. American authors (who prefer the term JRA) and European authors (who often use the term "juvenile chronic arthritis (JCA)") appear to have slightly different definitions of these disorders. The most recently adopted international nomenclature uses the term juvenile idiopathic arthritis JIA). Whatever name is chosen (JRA, JCA, or JIA), it requires that the arthritis is idiopathic, that is, not associated with any other recognisable condition. As, before the discovery of the microdeletion, the three patients were considered to have bona fide JRA by several rheumatologists in the three university hospitals where they were followed, and as a causal relationship with del(22ql 1) has still to be proven, we suggest that the erosive polyarthritis observed in association with del(22ql 1) should be described as a JRAlike disorder. Synovial puncture was not performed, so we have no idea of the cytological appearance of the articular fluid.
A JRA-like disorder has been reported in five children with del(22ql 1).' In the report of Rasmussen et al,4 onset was at 7 and 6 years, respectively. Both had positive antinuclear antibodies and one of them was positive for rheumatoid factor. HLA typing was not performed (S Rasmussen, personal communication). Interestingly, case 2 of Rasmussen et a' inherited the deletion from her father and had two deleted sibs: neither of them developed JRA. In the report of Sullivan et al,5 two boys and one girl were described with JRA and del(22ql 1). Onset was at 17 months, 19 months, and 5 years, respectively. One had positive antinuclear antibodies and all were negative for rheumatoid factor. They each had two HLA alleles associated with an increased risk of polyarticular JRA. The three children showed immunological anomalies: all three had impaired response to mitogens, two had IgA deficiency, the two youngest patients had abnormal CD4:CD8 T cell ratio, and the third one an increased ratio. In each case, as in our patients, the course was "subacute", polyarticular and there were no ocular complications nor systemic features such as rash, organomegaly, or lymphadenopathy and, apparently, only mild increase of inflammatory markers.
JRA is a common autoimmune disease of childhood. Its incidence is about 1/10 000 and its prevalence 1/1000. Although most cases are sporadic, many multiplex pedigrees have been observed in which JRA shows familial aggregation compatible with partially penetrant autosomal dominant inheritance.'920 One third to one half of the familial transmission is accounted for by linkage to the HLA loci2" 22 with predisposing alleles such as DR5, DR8, DP2. 1, DRB 1 (particularly DRB 1*0401), and DQB1, whereas linkage to DR1 or DR4, often observed in adult onset rheumatoid arthritis, is rarely noted in the paediatric population with positive rheumatoid factor. No linkage has been shown with chromosome 22.
The pathogenesis of JRA is complex,2' but a central role is attributed to T cells, as the only known function of DR is to present peptides to the CD4 T lymphocytes. Abnormal suppressor activity and abnormal immunoglobulin production are part ofJRA and point to an abnormal T cell function.23 As T cell dysfunction is a major component of DiGeorge syndrome, the association of autoimmune phenomenon with del(22ql 1) may not be coincidental, although the exact pathogenic mechanism remains to be solved. Rasmussen et a' noted that in their two families other members had joint problems. They speculated that JRA could occur for genetic reasons unrelated to the del(22ql1).
We would rather suggest that JRA is pathogenically related to del(22ql 1), the T cell dysfunction component of DiGeorge sequence being a possible adjuvant for developing JRA in those who have other predisposing factors (such as specific HLA subtypes 
